How Science Diplomacy Can Make a Difference in Global Health 11/03/2023 Editorial team Before the Framework Convention on Tobacco Control was adopted in 2003, the World Health Organization had worked for many years to prevent damage caused by tobacco consumption with the goal of passing an international agreement on tobacco regulation. The agreement, however, was not moving forward. “The real breakthrough came as scientific evidence emerged showing the […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> MPs to WHO: If You Want Pandemic Treaty Implemented, Engage with Us 06/12/2022 Maayan Hoffman Parliamentarians from around the world have called on the World Health Organization to engage civil society in the establishment of a “pandemic treaty,” if the organization hopes to have such a document not only ratified but also implemented. “The current process remains exclusionary,” said Giada Girelli, a senior analyst on human rights and justice at […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> MPs to WHO: If You Want Pandemic Treaty Implemented, Engage with Us 06/12/2022 Maayan Hoffman Parliamentarians from around the world have called on the World Health Organization to engage civil society in the establishment of a “pandemic treaty,” if the organization hopes to have such a document not only ratified but also implemented. “The current process remains exclusionary,” said Giada Girelli, a senior analyst on human rights and justice at […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
MPs to WHO: If You Want Pandemic Treaty Implemented, Engage with Us 06/12/2022 Maayan Hoffman Parliamentarians from around the world have called on the World Health Organization to engage civil society in the establishment of a “pandemic treaty,” if the organization hopes to have such a document not only ratified but also implemented. “The current process remains exclusionary,” said Giada Girelli, a senior analyst on human rights and justice at […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
With COVID Vaccine Supply Outstripping Vaccination Rates, Pharma Giants Question Pursuit of IP Waiver 13/04/2022 Kerry Cullinan Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control. “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading -> After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
After a “Lost Decade” – New WHO Alcohol Action Plan Offers Historic Chance to Address Health Risk to Billions 08/10/2021 Kristina Sperkova Long months of pandemic lockdown have only exacerbated the harms due to alcohol experienced by billions of people worldwide. Now, WHO is in the process of developing a new alcohol action plan, in an effort to re-energize a stagnant process and overcome a “lost decade” of little progress on alcohol policies. Can it make a […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> Posts navigation Older postsNewer posts